A patient with severe, chronic COPD uses an inhaled long-acting inhaled $\beta$₂ agonist (LABA)/glucocorticoid but continues to have frequent exacerbation of symptoms. What change in therapy will the provider discuss with the patient?

Question

Quizplus · Accepted Answer

Adding roflumilast, a phosphodiesterase-4 inhibitor, is an option for patients with severe COPD and chronic bronchitis, especially those with a history of frequent exacerbations, to reduce the risk of exacerbations when their symptoms are not adequately controlled by long-acting bronchodilators and inhaled corticosteroids.

A Patient with Severe, Chronic COPD Uses an Inhaled Long-Acting β\betaβ

A Patient with Severe, Chronic COPD Uses an Inhaled Long-Acting $\beta$